Impact of Expert Pathologic Review of Lymphoma Diagnosis: France

Impact of Expert Pathologic Review of Lymphoma Diagnosis: France

A diagnostic change between referral and expert review occurred in 19.7% of patients, with an estimated impact on patient care…

More...
Outcomes of Patients with Double-Hit Lymphoma who Achieve First Complete Remission

Outcomes of Patients with Double-Hit Lymphoma who Achieve First Complete Remission

Outcomes of patients with double hit lymphoma who receive an autologous stem cell transplant.

More...
Targeting Bruton Tyrosine Kinase with Ibrutinib in Relapsed/Refractory Marginal Zone Lymphoma

Targeting Bruton Tyrosine Kinase with Ibrutinib in Relapsed/Refractory Marginal Zone Lymphoma

Results of a clinical trial studying Ibrutinib for relapsed/refractory MZL.

More...

 

Global Database Search

 knowyoursubtype iconb   facebook2 twitter2 youtube1

logo europe

IN THE NODE

Updates

 

The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or require more detailed information on the best course of treatment for you.

Our website does not host any form of advertisement. Last updated: 05/30/17. Copyright © 2017 Lymphoma Coalition. All rights reserved.